Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the briefHow this story developed
3 reports over 3 days-
CNBC Top Stories Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market Neutral 0
-
CNBC Business You're reading this Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says Neutral 0
More like this







